NCT02543047View on ClinicalTrials.gov

The Angioshield Study Feasibility II

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 7, 2018

Conditions
Coronary Artery Disease
Interventions
DEVICE

Angioshield

Angioshield is applied to vein graft to provide Mechanical Support for Vein Grafts Used in CABG Surgery

Trial Locations (1)

LT-08661

Santariskiu University Hospital, Vilnius

All Listed Sponsors
lead

Neograft Technologies, Incorporated

INDUSTRY

NCT02543047 - The Angioshield Study Feasibility II | Biotech Hunter | Biotech Hunter